Bio-Rad Laboratories Inc Class A BIO

Morningstar Rating
$387.74 +1.16 (0.30%)
View Full Chart

Company Report

Price vs Fair Value

BIO is trading within a range we consider fairly valued.
Price
$386.48
Fair Value
LOCK|!^
Uncertainty
LOCK|D%
1-Star Price
^d?
5-Star Price
LOCK|mj
Economic Moat
LOCK|?^s
Capital Allocation
LOCK|@@kd!^z

Bulls Say, Bears Say

Bulls

Bio-Rad is a leader in niche areas including quality controls, antigens, and digital PCR, and it has a strong razor-and-blade model in clinical diagnostics.

Bears

Bio-Rad’s life science business currently faces a challenging environment due to funding cuts for US life sciences research and the potential for a weakening biotech funding environment.

News

Trading Information

Previous Close Price
$386.48
Day Range
$385.51–388.04
52-Week Range
$238.00–396.28
Bid/Ask
$387.41 / $388.37
Shares Outstanding
26.89M
Market Cap
$10.42B
Volume/Avg
44,359 / 255,859

Key Statistics

Price/Earnings (Normalized)
41.65
Price/Sales
4.02
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
0.76%

Company Profile

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Core
Total Number of Employees
7,450

Competitors

Valuation

Metric
BIO
TMO
SRT3
Price/Earnings (Normalized)
41.6529.0581.61
Price/Book Value
1.374.866.84
Price/Sales
4.025.675.49
Price/Cash Flow
79.6825.7527.05
Price/Earnings
BIO
TMO
SRT3

Financial Strength

Metric
BIO
TMO
SRT3
Quick Ratio
2.151.230.43
Current Ratio
3.181.811.07
Interest Coverage
26.335.524.03
Quick Ratio
BIO
TMO
SRT3

Profitability

Metric
BIO
TMO
SRT3
Return on Assets (Normalized)
2.55%8.32%3.58%
Return on Equity (Normalized)
3.63%17.48%12.52%
Return on Invested Capital (Normalized)
2.73%10.45%5.41%
Return on Assets
BIO
TMO
SRT3

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|?xXz!n$LOCK|DnSqn$191B
Medtronic PLC
MDT
LOCK|!%#qrbLOCK|LT!r^$130B
Stryker Corp
SYK
LOCK|YM#&K@lkLOCK|x?$123B
Boston Scientific Corp
BSX
LOCK|Ppc%@ZhLOCK|mHjmm$65B
Edwards Lifesciences Corp
EW
LOCK|>k^QQ!MnLOCK|<nZJl$60B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|vkDQ$m#LOCK|c^$38B
DexCom Inc
DXCM
LOCK|%vt>MBQLOCK|@@SNN$30B
Koninklijke Philips NV ADR
PHG
LOCK|SxLOCK|<<V$30B
Steris PLC
STE
LOCK|$kn>g&LOCK|#X>!$25B
Zimmer Biomet Holdings Inc
ZBH
LOCK|F@FZgB!LOCK|qKG$20B

Sponsor Center